ESC Congress 2005 Live Videos 

1 – ESC 2005

Introduction by Professor Michal Tendera, President of the ESC and Professor Michel Komajda, ESC Congress Programme Committee Chair

(3 mns 25 secs)

ESC 2005 Windows Media
ESC 2005 Quicktime 

2 – Women at Heart

Contrary to popular opinion, cardiovascular disease is the leading cause of death in women in Europe. 'Act and inform' is a mission endorsed by the European Society of Cardiology during its annual meeting as part of the « Women at Heart » campaign.

(2 mns 58 secs)

Women at Heart Windows Media
Women at Heart Quicktime

3 – Clinical Trials I

The results of the NORVIT trial (Randomised trial of homocysteine-lowering with B-vitamins for secondary prevention of cardiovascular disease after acute myocardial infarction), of the SOFA study (Study on Omega-3 Fatty acid and ventricular Arrhythmia) and of the ASCOT-BPLA (the Anglo-Scandinavian Cardiac Outcomes Trial: Blood Pressure-Lowering Arm)

(3 mns 10 secs)

Clinical Trials I Windows Media
Clinical Trials I Quicktime

4 - Images from ESC 2005

Discover the 2005 edition of « For your heart's sake » in Stockholm, the electronic posters, the Focus Sessions and the new Science Hot Line.

(5 mns 00 secs)

Images from ESC 2005 Windows Media
Images from ESC 2005 Quicktime

5 – Metabolic syndrome

Is the obesity and metabolic syndrome epidemic reaching the old continent ? Looking at the statistics, this unfortunately seems to be the case even if the definition of metabolic syndrome is evolving.  For metabolic syndrome, the therapeutic approach involves a change in lifestyle, this is one of the reasons why the European Society of Cardiology developed the EuroAction programme.

(3 mns 22 secs)

Metabolic syndrome Windows Media
Metabolic syndrome Quicktime

6 – Clinical Trials II

Results of the ISSUE II (the Implantable Loop Recorder allows a mechanism-based effective therapy in patients with recurrent suspected or certain neurally-mediated syncope), of the CLARITY-TIMI 28 (Clopidogrel as adjunctive reperfusion therapy-Thrombolysis In Myocardial Infarction) and of the ivabradine clinical trials programme.

(3 mns 28 secs)

Clinical Trials II Windows Media
Clinical Trials II Quicktime

7 – Heart Failure

Results of CIBIS III (Cardiac Insufficiency BIsoprolol Study III) ;  resynchronisation and CARE-HF (Long-term effects of cardiac resynchronisation on mortality in the CARE-HF Extension Study) ; the ESC recommendations on CHF.

(4 mns 52 secs)

Heart Failure Windows Media
Heart Failure Quicktime

8 – Acute myocardial infarction and revascularisation

The STEEPLE trial (Safety and Efficacy of Enoxaparin in Percutaneous Coronary Intervention Patients, an International Randomised Evaluation) and the OASIS 5 study (Efficacy and safety of fondaparinux compared to enoxaparin in 20,000 high risk patients with ACS without ST elevation) ;  the ASSENT4-PCI trial (ASsessment of the Safety and Efficacy of a New Treatment Strategy for Acute Myocardial Infarction) and the results of PREAMI (Perindopril and Remodelling in Elderly with Acute Myocardial Infarction).

(4 mns 12 secs)

AMI and revascularisation Windows Media
AMI and revascularisation Quicktime

9 – Physical activity

The improvement in endothelial dysfunction is demonstrated in a recent trial conducted in coronary patients following 4 weeks of exercise ; the risk of sudden death associated with sports can be screened and specifically managed.

Physical activity Windows Media
Physical activity Quicktime